It’s been another whirlwind year in the world of pharma marketing. | Updates on DTC advertising and DTP programs, as well as special reports, event coverage and, of course, news bulletins from the ...

Pharma marketers enter 2026 asking where DTC fits in the DTP era.  | Pharma marketers enter 2026 asking where DTC fits in the ...

Real-time measurement is key when proving how marketing is actually driving results for stakeholders and patients.

In the not too distant past, pharma lagged behind consumer advertising’s ability to churn out cutting-edge creativity. Weighed down by the regulatory, safety and compliance aspects that are par for ...

Kal Patel, M.D., is CEO and cofounder of BrightInsight. He has over 20 years of experience in pharma, medtech and regulated digital health. In recent conversations I’ve had with senior pharma leaders, ...

Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of the population, the increased prevalence of chronic disease and the growing ...

The digital marketing landscape is rapidly changing, as is the creative use of tools and mediums required for successful digital marketing campaigns. This is particularly true in the heavily regulated ...

The framework has had a lukewarm reaction, with trade association EFPIA saying the policies are “not strong enough”.

The rise of NP/PA influence is not a passing trend; it is a structural realignment of US healthcare. These clinicians are the ...

Luye Pharma Group ( ($HK:2186) ) has provided an announcement. Luye Pharma Group has granted Jiangsu Nhwa Hexin Pharmaceutical Marketing, a ...

Biotech firm Biocon on Tuesday said it has signed an out-licensing agreement with Ajanta Pharma to market its diabetes drug ...

Ajanta Pharma inked an in-licensing agreement with Biocon Ltd. for semaglutide, a GLP-1 receptor agonist. Zydus Lifesciences ...